Full-Text Search:
Home|Journal Papers|About CNKI|User Service|FAQ|Contact Us|中文
《Journal of Modern Oncology》 2015-18
Add to Favorite Get Latest Update

Prognostic evaluation of AFP in advanced hepatocellular carcinoma treated with sorafenib

Jin Chao;Du Xilin;Lu Jianguo;Department of General Surgery,Tang Du Hospital,Fourth Military Medical University;  
In recent years,targeted drugs like sorafenib have been the hotspot of comprehensive treatment of advanced hepatocellular carcinoma( HCC). However,there is not comprehensive evaluation indexes for the prognosis of advanced HCC. AFP( Alpha- fetoprotein) has been proved an important marker of HCC. And it is also thought to be possible in predicting prognostic of patients with advanced hepatocellular carcinoma. We summarize the relevant literatures about the prognostic evaluation of AFP in advanced HCC treated with sorafenib in recent years. It should be affirmed that the prognostic evaluation of AFP in advanced HCC treated with sorafenib. AFP can also be used as a supplement for the traditional evaluation criteria of HCC based on imaging studies. The significance of AFP as an predictor for prognosis of HCC treated with sorafenib is considerable in research and clinical application.
【CateGory Index】: R735.7
Download(CAJ format) Download(PDF format)
CAJViewer7.0 supports all the CNKI file formats; AdobeReader only supports the PDF format.
【Citations】
Chinese Journal Full-text Database 5 Hits
1 YU Jiami;WANG Xiaojie;GUO Zengqing;CHEN Yu;CHEN Ling;Internal medicine department,Fujjian Provincial Cancer Hospital;;Clinical Observation on the Sorafenib in the Treatment of Middle and Advanced Primary Hepatocellular Carcinoma[J];肿瘤药学;2014-05
2 TANG Daping;LIN Rujing;WANG Xuejian;Department of Surgery,Binyang County People's Hospital;;Sorafenib for patients with advanced hepatocellular carcinoma and the impact to alpha fetoprotein variation[J];疑难病杂志;2014-05
3 Li Liusheng;Huang Pinbo;He Chuanchao;Xiao Zhiyu;Department of Hepatobiliary Surgery, People's Hospital of Maoming;Department of Hepatobiliary Surgery, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University;;Effect of alpha-fetoprotein response for treatment of advanced hepatocellular carcinoma patients with sorafenib[J];岭南现代临床外科;2014-02
4 ;Comprehensive Treatment for Primary Liver Cancer[J];中国普外基础与临床杂志;2014-02
5 JIA Jia,QI Xingshun,HAN Guohong.(Department of Liver Disease and Digestive Interventional Radiology,Xijing Hospital of Digestive Disease,Fourth Military Medical University,Xi′an 710032,China);Prognostic value of α-fetoprotein response in treatment of hepatocellular carcinoma[J];临床肝胆病杂志;2013-08
【Co-citations】
Chinese Journal Full-text Database 9 Hits
1 YANG Min;LI Yuan;LEI Chang-jiang;LI Lei;FENG Jia-rui;GONG Xiao-jun;YANG Rui;Integrated Department, The Second Affiliated Hospital of Jianghan University;Department of General Surgery, The Second Affiliated Hospital of Jianghan University;;Regulation Mechanism of Glypican-3 on Hippo Signaling Pathway and Its Effects on Biological Behavior of Hepatocellular Carcinoma Huh7 Cells[J];中国普外基础与临床杂志;2016-11
2 BI Da-peng;ZHANG Xiao-xiao;The Sixth Ward,Tumor Hospital of Anshan City,Liaoning Province;The 12th Ward,Tumor Hospital of Anshan City,Liaoning Province;;Clinical study of transcatheter arterial chemoembolization combined with Sorafenib in the treatment of primary hepatic carcinoma[J];中国当代医药;2016-31
3 WU Ningni;ZHU Yiping;HE Yang;Department of Medical Oncology,The First Affiliated Hospital of Wannan Medical College;;Clinical observation on therapeutic effects of sorafenib in advanced hepatocellular cancer[J];皖南医学院学报;2016-04
4 Zhang Kedi;Tang Wenbo;Liu Rong;Department of Surgical Oncology,PLA General Hospital;;The study of clinical application of elevation paracentesis in laparoscopic ultrasonography-guided liver cancer radiofrequency ablation[J];中华腔镜外科杂志(电子版);2016-02
5 PENG Fang-hua;MA Xuan;HU Xiu-ying;General Hospital in Panjiang Investment Holding Co.Ltd.;Affiliated Hospital of Guizhou Medical University;;Effect of Hawthorn Extract on Apoptosis and Related Factors of HepG2 Cells[J];中国实验方剂学杂志;2016-07
6 TIAN Yun-hong;YANG Hong-chun;PENG Yong;MA Hai;LI Yong;LI Guan-yin;Department of Hepatobiliary Surgery,Nanchong Central Hospital,The Second Clinical Hospital of North Sichuan Medical College;;The Impact of Antivirus on Prognosis after Liver Resection for Hepatitis B-Related Hepatocellular Carcinoma[J];中国普外基础与临床杂志;2015-10
7 YOU Zhi-jian;ZHENG Rui-nian;HU Xia-rong;LIN Shun-huan;YE Zhen-wei;Department of Oncology,Dongguan People's Hospital;;Curative efficacy of transcatheter arterial chemoembolization combined with sorafenib for unresectable hepatocellular carcinoma[J];中国肿瘤临床与康复;2015-10
8 YANG Shuo;ZHANG Yunhui;SHI Min;LI Fengyi;CHEN Weiwei;ZHOU Zhiping;Team of Military Medical Science Academy of the PLA;Basic Medical Research Institute,Military Medical Science Academy of the PLA;;Changes in plasma vascular endothelial growth factor receptor 2 and alpha fetal protein after sorafenib administration for HBV related hepatocellular carcinoma[J];疑难病杂志;2015-09
9 GAO Fei;HAN Bin;PANG Zhi-gang;CHEN Wen-chao;Department of General Surgery,The Second Affiliated Hospital,Zhengzhou University;;Transcatheter Arterial Chemoembolization Combined with Sorafenib in Treatment of Intermediate or Advanced Hepatocellular Carcinoma of Chinese: A Meta Analysis[J];中国普外基础与临床杂志;2015-08
【Secondary Citations】
Chinese Journal Full-text Database 10 Hits
1 YANG Liu-qing;QIN Shu-kui;GONG Xin-lei;LIU Xiu-feng;HUA Hai-qing;XIA Zhao-jun;CHEN Ying-xia;WANG Lin;Cancer Center,People's Liberation Army 81 Hospital;;Clinical study on sorafenib for treating Chinese patients with advanced primary liver carcinoma[J];中国新药杂志;2013-17
2 ZHANG Zi-dong,JIA Guang-zhi.Department of Intervention,The Affiliated Hospital of Inner Mongolia Medical College,Hohhot 010050,China;Exploration of treatment and microsphere embolism in late-stage primary hepatocellular carcinoma with TACE and epirubicin[J];疑难病杂志;2013-03
3 BAI Wei,HAN Guohong.(Department of Liver Disease and Digestive Interventional Radiology,Xijing Hospital of Digestive Diseases,Fourth Military Medical University,Xi′an 710032,China);Comprehensive intervention treatment for hepatocellular carcinoma[J];临床肝胆病杂志;2013-01
4 Xin-Sen Xu,Kai Qu,Chang Liu,Jun Liu,Yan-Zhou Song,Peng Zhang,Si-Nan Liu,Hu-Lin Chang,Department of Hepatobiliary Surgery,The First Affiliated Hospital of Medical College,Xi'an Jiaotong University,Xi'an 710061,Shaanxi Province,China Yue-Lang Zhang,Department of Radiology,The First Affiliated Hospital of Medical College,Xi'an Jiaotong University,Xi'an 710061,Shaanxi Province,China;Highlights for α-fetoprotein in determining prognosis and treatment monitoring for hepatocellular carcinoma[J];World Journal of Gastroenterology;2012-48
5 XU Qiu-ran,ZHENG Xin,YAO Ying-min,YANG Wei,LIU Qing-guang(Department of Hepatobiliary Surgery,the First Affiliated Hospital, Medical School of Xi'an Jiaotong University,Xi'an 710061,China);Liver transplantation versus resection for treatment of hepatocellular carcinoma: A meta-analysis[J];西安交通大学学报(医学版);2012-05
6 CHEN Jian-guo.(Qidong Liver Cancer Institute,Qidong,Jiangsu 226200,China);Trends in the incidence of liver cancer and its primary prevention in China[J];临床肝胆病杂志;2012-04
7 WANG Yan,WANG Mao-qiang,LIU Feng-yong,WANG Zhi-jun,DUAN Feng,SONG Peng.Department of Interventional Radiography,Chinese PLA General Hospital,Beijing 100853,China;Sorafenib combined TACE for advanced hepatocellular ca rcinoma according to serum alpha-fetoprotein[J];中华临床医师杂志(电子版);2012-07
8 NIE Rong-hui,LIU Yuan-yuan(Department of Digestive Medicine,First Hospital,Jilin University,Changchun 130031,China);Application of detection of tumor markers AFP, CA125,CA199 and CEA in diagnosis and treatment for patients with hepatitis and liver cirrhosis[J];吉林大学学报(医学版);2012-01
9 Tian Hao,Cheng Zhaohui,Zhang Ruigang,Zhuang Guangxia(Department of Oncology,the People's Hospital of Xinyi,Xinyi 221400,China);The Clinical Effect of FOLFOX4 Regimen in the Treatment of Patients with Advanced Hepatocellular Cancer[J];肿瘤基础与临床;2011-06
10 Ministry of Health of the People's Republic of China;Diagnosis,management,and treatment of hepatocellular carcinoma(V2011)[J];临床肝胆病杂志;2011-11
©2006 Tsinghua Tongfang Knowledge Network Technology Co., Ltd.(Beijing)(TTKN) All rights reserved